Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Published Online
on August 20, 2007

Circulation. 2007
Published online before print August 20, 2007, doi: 10.1161/CIRCULATIONAHA.107.704346
A more recent version of this article appeared on September 4, 2007
This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Correction (v118,pe82)
Right arrow All Versions of this Article:
116/10/1185    most recent
CIRCULATIONAHA.107.704346v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cox, L. A.
Right arrow Articles by VandeBerg, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cox, L. A.
Right arrow Articles by VandeBerg, J. L.
Related Collections
Right arrow Risk Factors
Right arrow Functional genomics
Right arrow Gene expression
Right arrow Gene regulation
Right arrow Genetics of cardiovascular disease

Submitted on March 27, 2007
Accepted on June 25, 2007

Identification of Promoter Variants in Baboon Endothelial Lipase That Regulate HDL Cholesterol Levels

Laura A. Cox PhD*, Shifra Birnbaum BS, Michael C. Mahaney PhD, David L. Rainwater PhD, Jeff T. Williams PhD, and John L. VandeBerg PhD

From the Department of Genetics (L.A.C., M.C.M., D.L.R., J.T.W., J.L.V.), and Southwest National Primate Research Center (L.A.C., S.B., M.C.M., J.L.V.), Southwest Foundation for Biomedical Research, San Antonio, Tex.

* To whom correspondence should be addressed. E-mail: lcox{at}darwin.sfbr.org.

Background—High-density lipoprotein cholesterol (HDL) levels are a major risk factor for cardiovascular disease. Previously we identified a quantitative trait locus on baboon chromosome 18 that regulates HDL. From positional cloning studies and expression studies, we identified the endothelial lipase gene (LIPG) as the primary candidate gene for the quantitative trait locus. The mechanism by which LIPG variation influences HDL levels has not been determined.

Methods and Results—We identified 164 LIPG polymorphisms in a panel of sibling baboons discordant for HDL1 and genotyped putative regulatory polymorphisms in a population of 951 pedigreed baboons. With the use of quantitative trait nucleotide analysis we identified 3 polymorphisms in the LIPG promoter associated with variation in serum HDL1 levels. In addition, we demonstrated that these 3 polymorphisms affect LIPG promoter activity in vitro. In silico analysis was used to identify putative transcription factors that differentially bind the functional promoter polymorphisms.

Conclusions—These results reveal LIPG variants that specifically contribute to HDL1 levels and demonstrate mechanisms by which these polymorphisms may regulate LIPG promoter activity. Results from the present study provide a mechanism, namely variation in LIPG promoter activity possibly caused by altered transcription factor binding, by which LIPG variation affects HDL levels.


Key words: cardiovascular diseases • cholesterol • gene expression • genetic polymorphisms • genetics • genomics